Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Fellow Desjardins trader:

<< Previous

Bullboard Posts

Next >>

Comment by jomagon Nov 08, 2018 1:36pm

71 Views

Post# 28945157

RE:Fellow Desjardins trader:

V:ICO Depth by Order @13:32:30

Bid			Ask
Broker	Size	Price	Price	Size	Broker
9 BMO Nesbitt	22,000	0.08	0.085	6,000	1 Anonymous
1 Anonymous	10,000	0.08	0.085	7,000	79 CIBC
79 CIBC	10,000	0.08	0.09	25,000	7 TD Sec
7 TD Sec	3,000	0.08	0.09	105,500	85 Scotia
85 Scotia	25,000	0.08	0.09	6,189	79 CIBC
7 TD Sec	133,000	0.08	0.09	16,000	7 TD Sec
124 Questrade	40,000	0.08	0.095	15,000	2 RBC
19 Desjardins	3,000	0.08	0.095	20,000	7 TD Sec
7 TD Sec	30,000	0.08	0.10	20,000	79 CIBC
79 CIBC	7,000	0.08	0.10	66,000	7 TD Sec